recombinant human Complement Receptor Type 1 (CDX-1135) - Celldex
Catching up with Celldex Therapeutics (SeekingAlpha) - Aug 13, 2012 - Celldex about to begin a trial in renal disease for CDX-1135 
Anticipated new trial • Renal Disease
http://seekingalpha.com/article/803651-catching-up-with-celldex-therapeutics
 
Aug 13, 2012
 
Celldex has a surprisingly large early-stage pipeline, with drugs in human trials (CDX-1401, CDX-1127, and CDX-301) for solid tumors, lymphoma, and stem cell transplantation, and another (CDX-1135) about to begin a trial in renal disease... (IR7)